Biotech news
Refine search
Europe
A Lisbon judge rejects a bid to strike out the case over a drafting issue, offering insight into the court’s high bar for early dismissal. 2 April 2026
Americas
A long-running patent clash over gene editing returns to a fundamental question, as a US court takes another look at the evidence. 30 March 2026
Biotech
The Swiss pharma giant targets next-generation anti-IgE biologics as it looks to extend its dominance in the market. 27 March 2026
Biotech
As the world moves past the pandemic, a massive legal struggle over the future of mRNA technology is just hitting its stride. LSIPR visualises the litigation defining the next era. 25 March 2026
Europe
The European Patent Office’s Technology Dashboard reveals only a slight increase in medtech filings, and drops in biotech and pharma, against an overall healthy backdrop. 24 March 2026
Americas
Janssen seeks injunctive relief after a forensic review uncovers mass downloads of trade secrets spanning oncology, neuroscience and immunology portfolios. 17 March 2026
Americas
Law firms, companies and individuals have been shortlisted across a range of categories, which this year include new awards for excellence in PTAB, trade secrets and medical device work. 2 March 2026
Americas
The companies have agreed to dismiss their long-running patent fight over tumour-informed liquid biopsy technology, closing a high-stakes chapter in the fast-growing MRD testing market—while leaving the door open to future claims. 27 February 2026
Americas
In a decision with implications for biotechnology licensing and pharmaceutical manufacturing, the Ninth Circuit has rejected a ‘sweeping’ royalty trigger from a lower court. 26 February 2026
Careers
The New York hire brings broad litigation and transactional experience, including advising clients on artificial intelligence, biotech, pharma and chemical matters. 24 February 2026


